A new era dawns on sickle cell disease in India.
作者信息
Kishore R R, Gupta Mihir, Gupta Kalpna
机构信息
Indian Society of Health Laws & Ethics, New Delhi, India.
Department of Orthopedic Surgery & Neurological Surgery, Johns Hopkins University, Baltimore, MD, USA.
出版信息
Indian J Med Res. 2023 Jun;157(6):491-493. doi: 10.4103/ijmr.ijmr_1045_23.
Abstract
摘要
相似文献
1
A new era dawns on sickle cell disease in India.印度镰状细胞病迎来了一个新时代。
Indian J Med Res. 2023 Jun;157(6):491-493. doi: 10.4103/ijmr.ijmr_1045_23.
2
Therapeutic advances in sickle cell disease in the last decade.过去十年镰状细胞病的治疗进展
Indian J Med Res. 2017 Jun;145(6):708-712. doi: 10.4103/ijmr.IJMR_1153_17.
3
Newborn screening shows a high incidence of sickle cell anemia in Central India.新生儿筛查显示印度中部镰状细胞贫血的发病率很高。
Hemoglobin. 2012;36(4):316-22. doi: 10.3109/03630269.2012.691434. Epub 2012 Jun 19.
4
Sickle cell anemia from central India: a retrospective analysis.来自印度中部的镰状细胞贫血症：回顾性分析。
Indian Pediatr. 2012 Nov;49(11):911-3. doi: 10.1007/s13312-012-0217-z. Epub 2012 Jun 10.
5
Sickle cell disease in India: current status and progress.印度的镰状细胞病：现状与进展
Lancet Haematol. 2024 May;11(5):e322-e323. doi: 10.1016/S2352-3026(24)00109-1.
6
[Sickle-cell disease: geographical distribution and population estimates].[镰状细胞病：地理分布与人口估计]
Med Sci (Paris). 2013 Nov;29(11):965-7. doi: 10.1051/medsci/20132911012. Epub 2013 Nov 20.
7
A century after discovery of sickle cell disease: keeping hope alive!镰状细胞病发现百年之际：让希望长存！
Indian J Med Res. 2014 Jun;139(6):793-5.
8
Sickle cell disease: Status with particular reference to India.镰状细胞病：特别提及印度的现状。
Indian J Med Res. 2016 Jun;143(6):675-677. doi: 10.4103/0971-5916.191916.
9
Beta-globin gene cluster haplotypes linked to the betaS gene in western India.印度西部与βS基因相关的β珠蛋白基因簇单倍型
Hemoglobin. 2004 May;28(2):157-61. doi: 10.1081/hem-120034247.
10
Clinical diversity of sickle cell disease in western india - influence of genetic factors.印度西部镰状细胞病的临床多样性——遗传因素的影响
Acta Haematol. 2000;103(2):122-3. doi: 10.1159/000041032.
引用本文的文献
1
Sickle cell health awareness, perspectives and experiences (SHAPE) survey: perspectives on sickle cell disease (SCD) from healthcare providers in India, Malaysia, and Thailand.镰状细胞健康认知、观点与经历（SHAPE）调查：印度、马来西亚和泰国医疗服务提供者对镰状细胞病（SCD）的观点
Orphanet J Rare Dis. 2025 Jun 3;20(1):267. doi: 10.1186/s13023-025-03765-6.
2
Perceptions of patients and stakeholders on a prenatal sickle cell disease screening and its results among tribal populations of Gujarat: a participatory mixed-method research.古吉拉特部落人群中患者及利益相关者对产前镰状细胞病筛查及其结果的认知：一项参与性混合方法研究
J Community Genet. 2025 Apr;16(2):167-181. doi: 10.1007/s12687-025-00768-5. Epub 2025 Jan 21.
3
Sickle cell disease in India: the journey and hope for the future.印度的镰状细胞病：历程与未来的希望
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):1-9. doi: 10.1182/hematology.2024000678.
本文引用的文献
1
Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica.镰状细胞病多级护理建议标准的制定：来自非洲镰状细胞病项目的经验
Front Genet. 2023 Jan 12;13:1052179. doi: 10.3389/fgene.2022.1052179. eCollection 2022.
2
Assent, parental consent and reconsent for health research in Africa: thematic analysis of national guidelines and lessons from the SickleInAfrica registry.非洲卫生研究中的同意、父母同意和重新同意：国家指南的主题分析和 SickleInAfrica 登记处的经验教训。
BMC Med Ethics. 2022 Dec 8;23(1):130. doi: 10.1186/s12910-022-00843-3.
3
Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium.通过镰状细胞病泛非研究联盟开展医疗服务与研究的技能能力建设
Front Genet. 2022 Jun 15;13:805806. doi: 10.3389/fgene.2022.805806. eCollection 2022.
4
Younger age of stroke in low-middle income countries is related to healthcare access and quality.中低收入国家中风发病年龄较小与医疗保健的可及性和质量有关。
Ann Clin Transl Neurol. 2022 Mar;9(3):415-427. doi: 10.1002/acn3.51507. Epub 2022 Feb 9.
5
Genetic modifiers of long-term survival in sickle cell anemia.镰状细胞贫血长期生存的基因修饰因子
Clin Transl Med. 2020 Aug;10(4):e152. doi: 10.1002/ctm2.152.
6
Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?镰状细胞病的治愈性疗法与靶向疗法：解决根本原因是否比针对下游事件更有意义？
Blood Adv. 2020 Jul 28;4(14):3457-3465. doi: 10.1182/bloodadvances.2020001469.
7
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.估算患有镰状细胞病与不患有镰状细胞病患者的预期寿命和收入。
JAMA Netw Open. 2019 Nov 1;2(11):e1915374. doi: 10.1001/jamanetworkopen.2019.15374.
8
The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study.肯尼亚基利菲婴儿期入组儿童镰状细胞病的流行病学：一项前瞻性队列研究。
Lancet Glob Health. 2019 Oct;7(10):e1458-e1466. doi: 10.1016/S2214-109X(19)30328-6. Epub 2019 Aug 23.
9
Clinical manifestations of sickle cell disease in India: misconceptions and reality.印度镰状细胞病的临床表现：误解与现实。
Curr Opin Hematol. 2018 May;25(3):171-176. doi: 10.1097/MOH.0000000000000422.
10
Sickle cell disease.镰状细胞病。
Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1.
Zotero 插件